A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity ...

A new once-a-month injection helped people with obesity shed up to 16% of their body weight, offering fresh hope for effective, long-acting treatments. Can this breakthrough change the landscape for ...

Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new framework for the pharmacological treatment of obesity ...

Obesity is increasingly referred to as a chronic disease. This is also how it is defined in the recommendations of scientific societies. In practice, however, many women who decide to undergo ...

The field of obesity management has been significantly advanced by the introduction of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which have ...

European Commission grants authorization in adults and children 4 years of age and above with acquired hypothalamic obesity due to hypothalamic injury or impairment -- BOSTON, May 01, 2026 (GLOBE ...

The European Association for the Study of Obesity recommends the GLP-1 injectables semaglutide and tirzepatide as first-line treatments for most cases of obesity. This is due to their higher efficacy ...

AAP recommends a multimodal approach to childhood obesity, including lifestyle changes, pharmacotherapy, and bariatric surgery, emphasizing early intervention and expanded treatment access. Addressing ...

Obesity is not just “skin deep”; it is a chronic, complex disease. It is not a lack of willpower, a personal failure, or a ...

The workshop featured invited presentations and discussions that explore what is known about current obesity treatment approaches and the challenges involved in implementing them, including their ...

Amgen stock toppled Friday as investors digested its "generally in-line" first-quarter report and expansion in the obesity treatment space.